Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,043 | 9,611 | 19,992 | 4,539 | 14,822 |
| Marketable Securities | 45,110 | 58,962 | 53,051 | 79,047 | 74,914 |
| TOTAL | $62,052 | $69,435 | $73,755 | $84,035 | $90,179 |
| Non-Current Assets | |||||
| PPE Net | 1,734 | 1,701 | 1,244 | 608 | 397 |
| Investments And Advances | 5,120 | 1,903 | 4,590 | 0 | 0 |
| Other Non-Current Assets | 30 | 30 | 30 | 30 | 30 |
| TOTAL | $6,884 | $3,634 | $5,864 | $638 | $427 |
| Total Assets | $68,936 | $73,069 | $79,619 | $84,673 | $90,606 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 229 | 567 | 717 | 285 | 1,101 |
| Accrued Expenses | 1,460 | 1,328 | 2,491 | 2,688 | 1,730 |
| TOTAL | $1,689 | $1,895 | $3,208 | $2,973 | $2,831 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 26 | 33 | 40 | 46 | 37 |
| TOTAL | $26 | $33 | $40 | $46 | $37 |
| Total Liabilities | $1,715 | $1,928 | $3,248 | $3,019 | $2,868 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,891 | 19,839 | 19,836 | 19,809 | 19,792 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -69,609 | -64,662 | -58,602 | -52,182 | -45,087 |
| Other shareholders' equity | 33 | 18 | -50 | 4 | -1 |
| TOTAL | $67,221 | $71,141 | $76,371 | $81,654 | $87,738 |
| Total Liabilities And Equity | $68,936 | $73,069 | $79,619 | $84,673 | $90,606 |